5^th International Conference on Emerging Infectious Diseases August 27-28, 2021 Amsterdam, Netherlands

Track 01: EMERGING INFECTIOUS DISEASES

Emerging infectious diseases (EID) is defined as infectious diseases are freshly recognized during a population or have existed however is found increasing in incidence or geographic vary. Simply put, they'll be new infections ensuing from changes or evolution of existing organisms, illustrious infections spreading to new geographic areas or populations, antecedently unrecognized infections showing in areas undergoing ecologic transformation, or previous infections re-emerging as a result of antimicrobial resistance in illustrious agents or breakdowns publically health measures.

Track 02: CHAIN OF INFECTION

The Chain of infection is created of six completely different links: an infectious agent, reservoir, way of exit, mode of transmission, way of entry, and also the new host. Infectious agents (pathogens) embody not solely microorganism however conjointly viruses, fungi, and parasites. The virulence of those pathogens depends on their range, their efficiency, their ability to enter and survive within the body, and also the host susceptibility. Reservoir is defined as any person, animal, plant, arthropod, soil or any other substance (or combination of these) in which an infectious agent survives and multiplies easily. Portal of exit is the way by which a pathogen finds its exit from a reservoir. Mode of transmission is of two categories; Contact transmission refers to direct contact, as an example transmission from person-to-person. The agent gets transmitted because of physical contact between 2 people through actions like touching, snuggling and driblet sprays. Direct contact is characterized as vertical, horizontal and driblet transmission. In Vertical direct contact transmission, the microorganism gets transmitted from mother to the kid throughout physiological condition stage, birth, or through breastfeeding. Portal of Entry, Pathogenic agents can enter into the host through various portals of entry, such as the mucous membranes, non-intact skin, and the respiratory, etc. Susceptible host is someone who is at risk of infection and forms a final link in the chain of infection. 

Track 03: FACTORS CONTRIBUTING TO EMERGENCE OF INFECTIOUS DISEASES

Emerging infectious diseases and their basic causes gift a threat to the steadiness of countries and so the globe. Reasons for the emergence/reemergence of infectious diseases are advanced and interconnected. Specific factors causing the emergence of a malady will typically be known. These embody ecological, environmental or demographic factors that place individuals in enhanced contact with the natural host for a antecedently unacquainted with animal disease agent or that promote the unfold of the infectious agent. These factors are getting more and more current, suggesting that infections can still emerge and possibly increase.

Track 04: ZOONOTIC DISEASES

Animals carry harmful germs like viruses, bacterial, parasites, and fungi that can sometimes spread to people and cause diseases. These are called as zoonotic diseases or zoonoses. The disease caused by these germs can cause variety of infections, ranging from mild symptoms to serious illnesses and sometimes even death. A healthy looking animal also carries germs that make a person sick, depending on the zoonotic disease. Because of the close association among people and animals, it’s really important to pay attention on the common ways people can get diseased with germs that can cause zoonotic diseases. These can include: Direct contact, indirect contact, Vector-borne, Foodborne & Waterborne.

Related Conferences: Emerging infectious disease Conference | Infectious Diseases Congress | Foodborne disease conference | Waterborne disease conference | Nosocomial Infections | Novel Coronavirus conferences | Dermatological Infectious Diseases Conferences  | Disease Conferences | Gastrointestinal disease conference

Track 05: VECTOR BORNE DISEASES

Vector-borne diseases are human diseases caused by parasites, viruses and bacterium that square measure transmitted by vectors. Each year there are about 700,000 deaths from diseases like protozoal infection, dengue, infection, human African trypanosomiasis, leishmaniosis, Chagas illness, infectious disease, Japanese phrenitis and river blindness. The burden of those diseases is highest in tropical and semitropic areas, and that they disproportionately have an effect on the poorest populations. Since 2014, major outbreaks of dengue fever, malaria, chikungunya, infectious disease and Zika have afflicted populations, claimed lives, and overcome health systems in several countries. Other diseases like Chikungunya, leishmaniosis and humour disease cause chronic suffering, life-long morbidity, incapacity and occasional stigmatization. Distribution of vector-borne diseases is set by a fancy set of demographic, environmental and social factors.

Related Conferences: Emerging infectious disease Conference | Infectious Diseases Congress | Foodborne disease conference | Waterborne disease conference | Nosocomial Infections | Novel Coronavirus conferences | Dermatological Infectious Diseases Conferences  | Disease Conferences | Gastrointestinal disease conference

Track 06: AIR, WATER & FOOD BORNE INFECTIONS

Airborne disease can spread when people with some infections cough, sneeze, or talk, spewing nasal and throat secretions into the air. When one breathes in, the airborne pathogenic organisms enter into the host organism. One can also catch germs while touching a contaminated surface and then their own eyes, nose, or mouth. As these pathogenic organisms travel in the air, they’re difficult to control. Some examples of airborne diseases are Covid-19, chickenpox, measles, etc.  

Water borne diseases is transmitted through ingestion of contaminated or polluted water.Many infections may be spread by microbes or parasites that by mistake, probably as an effect of exceptional conditions, have contacted the water. However, the fact that there might be a random infection does not mean that it is fair to classify the resulting disease as waterborne disease. Some of the waterborne diseases include Diarrhea, Typhoid, cholera, etc.

Food borne diseases are caused by contamination of food that can occur at any point of the food production, its delivery and during its consumption. This will result from many sorts of environmental contamination as well as pollution present in water, soil or air.
Foodborne diseases often lead to duct problems. Some of the common foodborne diseases are caused by Norovirus, Salmonella, Escherichia coli.

Related Conferences: Emerging infectious disease Conference | Infectious Diseases Congress | Foodborne disease conference | Waterborne disease conference | Nosocomial Infections | Novel Coronavirus conferences | Dermatological Infectious Diseases Conferences  | Disease Conferences | Gastrointestinal disease conference

Track 07: NOSOCOMIAL INFECTIONS

Nosocomial infections, also named as healthcare-associated or sometimes hospital acquired infections, are a subgroup of infectious diseases acquired in a health-care facility. These infections often lead to serious complications like sepsis and even death. These infections are usually caused by multidrug-resistant strains of pathogens acquired due to improper and excessive use of antibiotics and not following infection control and prevention measures. Bacteria, Fungi and Viruses can cause such type of infection. Most common organism is Staphylococcus aureus bacterium. Examples include urinary tract infection; surgical site wound infections, respiratory pneumonia, and many more. Nosocomial pathogenic agents are transmitted from one person to another, environment or through contaminated food and water, contaminated skin of healthcare personnel or via shared items and surfaces.

Related Conferences: Emerging infectious disease Conference | Infectious Diseases Congress | Foodborne disease conference | Waterborne disease conference | Nosocomial Infections | Novel Coronavirus conferences | Dermatological Infectious Diseases Conferences  | Disease Conferences | Gastrointestinal disease conference

Track 08: GASTROINTESTINAL INFECTIONS

Gastrointestinal infections are infective agent, microorganism or parasitic infections that cause intestinal flu.. Symptoms embody diarrhea, vomiting, and abdominal pain. Dehydration is that the main danger of GI infections, thus rehydration is vital, however most GI infections area unit end and resolve among many days. However, in an exceedingly aid setting and in specific populations (newborns/infants, immunocompromised patients or older populations), they're probably serious. fast diagnosing, applicable treatment and infection management measures area unit so notably vital in these contexts. Gastrointestinal infections are often caused by an outsized range of microorganisms, including; 

Adenovirus will cause diarrhea, fever, redness, bladder infections and rashes, however the foremost common symptom is disease. When Reovirus, it's the foremost common reason behind paediatric diarrhea. Campylobacter is one in every of the foremost common microorganism reason behind intestinal flu worldwide and is frequent in kids beneath 2. It will cause diarrhea (sometimes bloody), abdominal cramps, reflex and fever. It's sometimes food-borne through raw or undercooked meat (especially poultry) or through contaminated milk. Escherichia coli, typically known as E. coli, is the leading reason behind travelers’ diarrhea and a significant reason behind diarrheic illness within the developing world, particularly among kids. Folks sometimes contract E. coli through bodily function of water contaminated with human or animal excretory product.

Related Conferences: Emerging infectious disease Conference | Infectious Diseases Congress | Foodborne disease conference | Waterborne disease conference | Nosocomial Infections | Novel Coronavirus conferences | Dermatological Infectious Diseases Conferences  | Disease Conferences | Gastrointestinal disease conference

Track 09: DERMATOLOGICAL INFECTIONS

Skin infections are caused by a large sort of germs, and symptoms will vary from delicate to serious. Delicate infections could also be treatable with over-the-counter medications and residential remedies, whereas alternative infections might need medical attention.

There four differing types of skin infections:

1. Bacterial skin infections
Bacterial skin infections usually begin as tiny, red bumps that slowly increase in size. Some microorganism infections area unit delicate and simply treated with topical antibiotics, however alternative infections need associate degree oral antibiotic. Different types of microorganism skin infections include: impetigo & boils.

2. Viral skin infections
Viral skin infections area unit caused by a deadly disease. These infections vary from delicate to severe. Different  types of infective agent infections include: shingles (herpes zoster) & varicella

3. Fungal skin infections
These sorts of skin infections area unit caused by a plant and area unit possibly to develop in damp areas of the body, like the feet or bodily cavity. Some fungous infections aren’t contagious, and these infections area unit usually non-life-threatening. Different types of fungus infections: athlete’s foot &yeast infection

4. Parasitic skin infection
These sorts of skin infections area unit caused by a parasite. These infections will unfold on the far side the skin to the blood and organs. A parasitic infection isn’t dangerous however are often uncomfortable. Different  types of parasitic skin infections include: lice & scrabies.

Related Conferences: Emerging infectious disease Conference | Infectious Diseases Congress | Foodborne disease conference | Waterborne disease conference | Nosocomial Infections | Novel Coronavirus conferences | Dermatological Infectious Diseases Conferences  | Disease Conferences | Gastrointestinal disease conference

Track 10: HIGHLY PATHOGENIC EMERGING DISEASES IN HUMANS (SARS & MERS)

Severe acute respiratory syndrome (SARS) may be a infective agent respiratory illness caused by a SARS-associated coronavirus. Severe acute respiratory syndrome may also be unfold indirectly via surfaces that are touched by somebody United Nations agency is infected with the virus. The period of time of severe acute respiratory syndrome is typically 2-7 days however could also be as long as ten days. The primary symptom of the health problem is usually fever (>38°C), that is commonly high, and generally related to chills and rigors. It is going to even be in the middle of different symptoms as well as headache, malaise, and muscle pain.

Middle East respiratory syndrome (MERS) may be a infective agent respiratory illness caused by a unique coronavirus) that was 1st known in Asian nation in 2012. Coronaviruses square measure an oversized family of viruses that may cause diseases starting from the respiratory disease to Severe Acute metabolic process Syndrome (SARS). Typical MERS symptoms embrace fever, cough and shortness of breath. Respiratory disease is common, however not invariably gift. Duct symptoms, as well as symptom, have conjointly been according. Some laboratory-confirmed cases of MERS-CoV infection square measure according as well, which means that they are doing not have any clinical symptoms; however they're positive for MERS-CoV infection following a laboratory check. Most of those well cases are detected following aggressive contact tracing of a laboratory-confirmed case.

Related Conferences: Emerging infectious disease Conference | Infectious Diseases Congress | Foodborne disease conference | Waterborne disease conference | Nosocomial Infections | Novel Coronavirus conferences | Dermatological Infectious Diseases Conferences  | Disease Conferences | Gastrointestinal disease conference

Track 11:  MULTIDRUG RESISTANT STRAINS OF PATHOGENS

The resistance among numerous microorganism species (infectious agents) to totally different antimicrobial medicine has emerged as a reason for public health threat everywhere the planet at a terrific rate. Because of the pacing advent of recent resistance mechanisms and reduce in potency of treating common infectious diseases, it ends up in failure of microorganism response to straightforward treatment, resulting in prolonged unwellness, higher expenditures for health care, associated an vast risk of death. The majority the capable infecting agents (e.g., bacteria, fungi, virus, and parasite) have used high levels of multidrug resistance (MDR) with increased morbidity and mortality; therefore, they're observed as “super bugs”.

Track 12: EVOLUTION & ECOLOGY OF INFECTIOUS DISEASES

The emergence and therefore the re-emergence of diverse infectious diseases round the world have coincided with new rates of modification within the structure and variety of the setting and human social and economic systems. Nearly all of the world's terrestrial and aquatic ecosystems have undergone dramatic changes because of a spread of human activities like surroundings transformation, human displacement and relocation, urbanization, use of antimicrobial agents in agriculture and medication, and global climate change. The coincidence of broad scale environmental changes, the growth of human social and economic networks, and therefore the emergence and re-emergence of infectious diseases might purpose to underlying inevitable ecological and eco-evolutionary relationships.

Track 13: APPROACHES FOR DIAGNOSIS OF EMERGING DISEASES

Molecular diagnostics continues to evolve terribly quickly, and its impact within the designation of infectious diseases is plain. Molecular tools have a crucial role in discovering and characterizing many rising infectious agents and have currently become the gold commonplace for the designation of infectious diseases caused by fastidious or uncultivated agents. Multiple challenges still stay for the widespread use of efficient, validated, and commercially accessible molecular tools. Machine-controlled instruments capable of sample process and multiplex macromolecule amplification and post amplification analysis have already been approved by the North American nation Food and Drug Administration (FDA) to be used within the clinical setting. Nanobiotechnology is commencing to impact laboratory medical specialty within the clinical setting

Track 14: PREVENTIVE MEASURES FOR DISEASE CONTROL

The infectious diseases could also be prevented in one in all two general ways: (1) by preventing contact, and so transmission of infection, between the prone host and also the supply of infection and (2) by rendering the host unsusceptible , either by selective breeding or by induction of a good artificial immunity. The character of the particular preventive measures, and their effectiveness, varies from one illness to a different.

Track 15: VACCINOLOGY & EPIDEMIOLOGY

Vaccines, are biological measures that improve immunity for a particular disease, are an important part of disease prevention and one of the most economical investments in health and economic development. Vaccination can prevent the suffering and death linked with infectious diseases like polio, measles, and pneumonia. Yet, the World Health Organization (WHO) estimates that 1.5 million children under five years of age lose their lives to vaccine-preventable diseases every year.

Literature reveals that about 60% of all human infectious diseases known till now, and approximately 75% of the emerging diseases that have affected people over the last three decades had a zoonotic characteristic. Scientific research conducted indicates that some areas of the world are likely to experience the emergence of new infectious diseases. Over the last 30 years, about 30 new infectious diseases have emerged and threatened the health of millions of people, worldwide. The main challenge to fight these infections is that for many diseases, there is no specific cure or vaccine available.

 

Summary

This two-day international conference will provide practical evidence-based strategies for mobilising your workforce and reducing the spread of active health infections. The objective of Emerging Infectious Diseases Conference 2021 is to promote the health perspective, including plenary speeches, round tables, symposiums, abstracts, and workshops on emerging infectious diseases. The goal is to bring together a multidisciplinary group to identify key disease issues in Europe, the USA and Asia-Pacific, the Middle East and elsewhere in the world. Participating will be scientists, Infectious Diseases Researchers, doctors, clinicians, nurses, patients, government officials and drug company representatives. The following are the conference recommendations to develop a global action plan for infectious diseases. This summary presents the conference's recommendations. It includes measures proposed to participate in the conference by the plenary speakers, the lecturers and the student assembly.

Importance and Scope

An emerging meeting on infectious diseases combines various practises that properly limit the spread of infection. The knowledge is required in all healthcare environments to prevent the transmission of transmissible diseases. The conference's concept requires a basic understanding of disease epidemiology; the importance of prevention measures and bundles during the renovation work of hospitals to protect the patient from infections that are related to the environment. The implementation of the infection-control programme, in healthcare facilities, is essential also for health care administrators.

This is also a major problem for patient safety and can also be a problem for occupational health and safety. A well-functioning awareness programme reduces patient risks. The role of each health workers in public health practise must be understood, incorporated into daily activities and shared between others.

Members Associated with Emerging Infectious Diseases Research

The objective of the Health Care initiative conference EMERGING INFECTIOUS DISEASE 2021 was to help reduce the dissemination of health care-related infections, helping assess, plan, implement and evaluate national infection control policy. The ultimate aim is to promote quality health care, which is safe in the field of Infectious Diseases, for patients, health workers and others in the health sector and the environment.

Major Infectious Diseases Research Associations around the World

British Infection Association |  Infectious Disease Society of America | Infectious Diseases Research Network | European Society for Clinical Microbiology and Infectious Diseases | British Society for Antimicrobial Chemotherapy | British HIV Association | The Hospital Infection Society | Infection Prevention Society | The Royal Society of Tropical Medicine and Hygiene | UK Clinical Virology Network | World Health Organization | Royal Society for Public Health | Health Protection Scotland | The Society of Health care Epidemiology of America | Johns Hopkins University, United States | Karolinska University, Sweden | Pfizer,USA.

Market Research on Emerging Diseases:

The global market size for infectious diseases is expected to increase at CAGR of 6.6 percent during the projected year by USD 46.88 billion in 2019. The growth of this market will likely be driven by increasing prevalence of infectious diseases, increasing costs to boost the penetration rate of treatment of those diseases, growing awareness initiatives on treatments and diagnostics, and increasing clinical trials for the development of new drugs. In 2018, 45.9% of the market in the HIV segment was in the highest proportion.

According to a new market research report “Infectious Disease Diagnostics Market by Product and Solution (Consumables, System, Software and Services), Technology (Immunodiagnostics, PCR, INAAT), Disease (HIV, HAIS, Influenza), End User (Hospital, Reference Lab, Research) - Global Forecast to 2027”, printed by Meticulous Research®, the infectious disease diagnostics market is estimated to raise at a CAGR of 6.9% from 2020 to touch $42.85 billion by 2027.

COVID-19 Impact on the Infectious Disease Diagnostics Market

The increasing demand for diagnostic products for infectious diseases and HAIs around the globe has increased. In several countries all over the world, the recent outbreak of COVID-19 has led to destruction. The disease has spread too many countries around the world since its outbreak in November 2019. In response to the increased COVID-19 pandemic and the lack of molecular testing capacity and reagents in a laboratory, several diagnosis test manufacturers have designed and started to sell quick and easy-to-use testing devices. These simple test kits are either based on the detection in respiratory samples of COVID-19 proteins (sputum and throat swab). This pandemic therefore creates opportunities for various sellers operating in this market in increasing production & approval of COVID-19 kits.

Scope of the Report:

Infectious Disease Diagnostics Market by Product & Solution

• Consumables
• Instruments
• Software & Services

Infectious Disease Diagnostics Market by Technology

• Immunodiagnostics
• Clinical Microbiology
• Polymerase Chain Reaction
• Isothermal Nucleic Acid Amplification Technology
• DNA Sequencing and Next-Generation Sequencing (NGS)
• DNA Microarray Technology

Infectious Disease Diagnostics Market by Disease Type

• Hepatitis
• Human Immunodeficiency Virus (HIV)
• Hospital-Acquired Infections (HAIS)
• Human Papillomavirus (HPV)
• Tuberculosis (TB)
• Influenza
• Other diseases comprise of measles, small pox, mumps, typhoid fever, malaria, meningitis, Ebola virus disease, Lyme disease, coronavirus disease, and whooping cough.

Infectious Disease Diagnostics Market by End User

• Hospital/Clinical Laboratories
• Reference Laboratories
• Academics/Research Institutes
• Other end users comprise of physician offices, nursing facilities, and home healthcare agencies

Infectious Disease Diagnostics Market by Geography

• North America
• U.S.
• Canada
• Europe
• Germany
• France
• U.K.
• Italy
• Spain
• Rest of Europe (RoE)
• Japan
• China
• India
• Rest of APAC (RoAPAC)
• Asia-Pacific (APAC)
• Latin America
• Middle East & Africa